Ebola vaccines to be shipped to DRC, WHO chief says


On 8 May 2018, WHO was notified by the Ministry of Health of the Democratic Republic of the Congo of two confirmed cases of Ebola virus disease occurring in Bikoro health zone, Equateur province.

In a press conference given in Geneva on Friday, Peter Salama, head of the WHO's emergency response, told reporters the global health organization is taking the newest outbreak of this Ebola virus very seriously.

Ebola is endemic to the Democratic Republic of Congo, and this is the nation's ninth outbreak of Ebola virus disease since the discovery of the virus in the country in 1976.

The funds, he said, "in effect had the potential to function as something we very, very badly need, which is a contingency fund for significant large-scale disease outbreak". Fortunately, the DRC, which has had more Ebola outbreaks than any other country, has developed effective ways of controlling the virus. Previous year eight cases were reported, and half of the infected people died.

The government has moved to assure that no case of Ebola has been reported in the country despite a recent outbreak of the unsafe virus in the Democratic Republic of Congo. Those who help bury or clean the bodies of the infected are also at high risk.

Ebola's potential to spread rapidly is the reason it's essential to have dedicated officials coordinating a response to an outbreak before it turns into a deadly epidemic or pandemic.

The WHO was especially concerned about the possible spread to neighbouring Republic of Congo and the Central African Republic, which have connections to the affected area through the river systems.

It has been revealed that over 80 per cent of the population will be needed to get immunised to prevent outbreak of the disease.

The WHO is moving quickly, having been criticised for bungling its response to a 2014-2016 outbreak that killed more than 11,300 people in Guinea, Sierra Leone and Liberia.

Symptoms of Ebola include fever, severe headache, muscle pain, diarrhea, vomiting and unexplained bruising or bleeding.

This could have a benefit since it could slow down the spread of Ebola, but it also greatly complicates the response. There are now no clinical vaccine candidates available that protect against all four human-pathogenic Ebola viruses.

Nigeria had been announced with Ebola in October 2014 from the World Heath Organization, right after 42 days had passed considering that tests showed that the infected person no further experienced the disorder.